To boost the understanding of the genomic bases of rare as well as common diseases, the National Institutes of Health (NIH) has announced its decision to earmark funds towards genome sequencing and analysis centres.
The National Human Genome Research Institute (NHGRI) announced the next phase of the Centers for Mendelian Genomics (CMG), which investigates the genomic underpinnings of rare diseases. Here scientists will “build on an international network of research collaborations and sequence the genomes of individuals with a wide range of rare disorders seen around the world.”
Pending the availability of funds, NHGRI will provide CMG programs with roughly USD 40 million, over four years. NHGRI will also fund a new Coordinating Center for approximately $4 million over four years to facilitate research collaborations among the program grantees, and to contribute to data analysis and program outreach. Additionally the National Heart, Lung, and Blood Institute the National Eye Institute will provide support to the CMG program.